C/M CAPITAL PARTNERS, LP

13D and 13G Filings

13D/G filings: 13G on 10 securities
CIK: 0002038499
All SEC filings: View on sec.gov

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Schedule 13G · 10 securities · passive
Endovia Health Sciences, Inc. 13G EDVA · 84862C401	EDVA	84862C401	7.2%	797,592	13G	10/22/2026 Event 10/15/2026
C/M Capital Master Fund, LP			7.2%	797,592
C/M Capital Partners, LP			7.2%	797,592
Thomas Walsh			7.2%	797,592
Jonathan Juchno			7.2%	797,592
Catheter Precision, Inc. 13G VTAK · 74933X708	VTAK	74933X708	10.0%	1,597,328	13G	8/21/2026 Event 8/16/2026
C/M Capital Master Fund, LP			5.5%	878,451
WVP Emerging Manager Onshore Fund LLC			5.5%	878,451
C/M Capital Partners, LP			10.0%	1,597,328
Thomas Walsh			10.0%	1,597,328
Jonathan Juchno			10.0%	1,597,328
Volato Group, Inc. 13G SOAR · 74349W302	SOAR	74349W302	6.2%	3,294,563	13G	7/6/2026 Event 6/27/2026
C/M Capital Master Fund, LP			6.2%	3,294,563
C/M Capital Partners, LP			6.2%	3,294,563
Thomas Walsh			6.2%	3,294,563
Jonathan Juchno			6.2%	3,294,563
Beeline Holdings, Inc. 13G BLNE · 277802500	BLNE	277802500	6.2%	1,932,499	13G	6/4/2026 Event 5/28/2026
C/M Capital Master Fund, LP			3.4%	1,054,617
Cavalry Fund I LP			0.4%	114,508
C/M Capital Partners, LP			3.7%	1,169,125
Cavalry Investment Fund, LP			2.4%	763,374
Cavalry Fund I Management LLC			2.4%	763,374
Thomas Walsh			6.2%	1,932,499
Jonathan Juchno			3.7%	1,169,125
Biodexa Pharmaceuticals Plc 13G/A BDRX · 59564R880	BDRX	59564R880	0%	0	13G/A	11/14/2025 Event 6/30/2025
Cavalry Fund I LP			0%	0
C/M Capital Partners, LP			0%	0
Cavalry Investment Fund, LP			0%	0
Cavalry Fund I Management LLC			0%	0
Mercer Street Global Opportunity Fund, LLC			0%	0
Mercer Street Capital Partners, LLC			0%	0
Thomas Walsh			0%	0
Jonathan Juchno			0%	0
Forward Industries, Inc. 13G/A FWDI · 349862409	FWDI	349862409	1.6%	1,381,368	13G/A	11/14/2025 Event 9/30/2025
C/M Capital Master Fund, LP			0.4%	338,907
C/M Capital Partners, LP			1.6%	1,381,368
Thomas Walsh			1.6%	1,381,368
Jonathan Juchno			1.6%	1,381,368
Heritage Distilling Holding Company, Inc. 13G/A IPST · 42727R104	IPST	42727R104	0%	0	13G/A	11/14/2025 Event 9/30/2025
C/M Capital Master Fund, LP			0%	0
C/M Capital Partners, LP			0%	0
Thomas Walsh			0%	0
Jonathan Juchno			0%	0
Auddia Inc. 13G/A AUUD · 05072K305	AUUD	05072K305	0%	0	13G/A	11/14/2025 Event 9/30/2025
Cavalry Fund I LP			0%	0
WVP Emerging Manager Onshore Fund LLC			0%	0
C/M Capital Partners, LP			0%	0
Cadence Hill Opportunity Fund, LP			0%	0
Cavalry Fund I Management LLC			0%	0
Thomas Walsh			0%	0
Jonathan Juchno			0%	0
Salarius Pharmaceuticals, Inc. 13G DCOY · 79400X503	DCOY	79400X503	0%	0	13G	10/14/2025 Event 10/7/2025
C/M Capital Master Fund, LP			0%	0
C/M Capital Partners, LP			0%	0
Thomas Walsh			0%	0
Jonathan Juchno			0%	0
Biodexa Pharmaceuticals Plc 13G BDRX · 59564R807 Amended under CUSIP 59564R880 on 11/14/2025	BDRX	59564R807	6.8%	1,752,390,000	13G	5/28/2025 Event 5/20/2025
Cavalry Fund I LP			5.7%	1,460,870,000
C/M Capital Partners, LP			5.7%	1,460,870,000
Cavalry Investment Fund LP			0.3%	74,830,000
Cavalry Fund I Management LLC			0.3%	74,830,000
Mercer Street Global Opportunity Fund, LLC			1.1%	291,520,000
Mercer Street Capital Partners, LLC			1.1%	291,520,000
Thomas Walsh			6.0%	1,535,700,000
Jonathan Juchno			6.8%	1,752,390,000

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.